MYCN is a gene that can affect outlook (prognosis) in a childhood cancer called neuroblastoma. Some children with neuroblastoma have too many copies of this gene. This is called ‘gene amplification’. Doctors think that children with too many copies of the MYCN gene may not respond as well to standard treatment for neuroblastoma as children who do not have MYCN gene amplification.